PAX3 and PAX7 Binding Protein 1 (PAXBP1) (C-Term) Peptid
PAXBP1
Reaktivität: Human
Wirt: Synthetic
BP, WB
Produktnummer ABIN974194
Kurzübersicht für PAX3 and PAX7 Binding Protein 1 (PAXBP1) (C-Term) Peptid (ABIN974194)
Target
PAX3 and PAX7 Binding Protein 1 (PAXBP1)
Spezies
Human
Quelle
Synthetic
Applikation
Blocking Peptide (BP), Western Blotting (WB)
Protein Region
C-Term
Produktmerkmale
This is a synthetic peptide designed for use in combination with anti-C21orf66 antibody (Catalog #: ARP47636_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
Each Investigator should determine their own optimal working dilution for specific applications.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
Konzentration
1 mg/mL
Buffer
Final peptide concentration is 1 mg/mL in PBS.
Handhabung
Avoid repeated freeze-thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
Target
PAX3 and PAX7 Binding Protein 1 (PAXBP1)
Hintergrund
Similarity to a transcriptional repressor suggests that C21orf66 is involved in the regulation of transcription. Alternative splicing of this gene results in three transcript variants encoding different isoforms. Additional transcript variants have been described, but their full-length sequences have not been determined. Similarity to a transcriptional repressor suggests that this gene's protein product is involved in the regulation of transcription. Alternative splicing of this gene results in three transcript variants encoding different isoforms. Additional transcript variants have been described, but their full-length sequences have not been determined.
Alias Symbols: BM-020, FLJ90561, GCFC, BM020, FSAP105, C21orf66